Form D · Other Health Care
Ventricle Health, Inc.
Greensboro, X1 · CIK 0002000394
Offering snapshot reported Nov 13, 2023 · SEC filing
- Reported sold
- $8M Offering amount: $8M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 26, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 13, 2023 | Initial | $7,999,995 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-497054
Chief Medical Officer
Source: Form D, filed Nov 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Bensimhon | Director |
| Carie Cotter | Director |
| Anurag Kondapalli | Director |
| Sean O'donnell | Director, Executive |
| Matthew Soule | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1150 Revolution Drive, Studio 6
Greensboro, X1, 27405
Greensboro, X1, 27405